These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6523451)

  • 21. Effects of compound 48-80 on platelets: structural alterations and inhibition of aggregation.
    Ts'ao C; Glagov S
    Scand J Haematol; 1972; 9(1):73-82. PubMed ID: 5056482
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calmodulin antagonist W-7 inhibits aggregation of human platelets induced by platelet activating factor.
    Levy JV
    Proc Soc Exp Biol Med; 1983 Mar; 172(3):393-5. PubMed ID: 6844347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of bradykinin on the effect of plasma kallikrein on platelet aggregation.
    Maeda NY; Cassaro CM; Sampaio MU; Chamone DA; Sampaio CA
    Adv Exp Med Biol; 1989; 247B():623-6. PubMed ID: 2514583
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desensitization of human platelets by platelet activating factor.
    Chesney CM; Pifer DD; Huch KM
    Biochem Biophys Res Commun; 1985 Feb; 127(1):24-30. PubMed ID: 3977920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of inorganic ions and plasmatic factors in ADP collagen, thrombin induced platelet aggregation.
    Leone G; Boni P; Alfano G; Bizzi B
    Haematologica; 1977 Aug; 62(4):378-91. PubMed ID: 409646
    [No Abstract]   [Full Text] [Related]  

  • 29. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M
    Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists.
    Bednar B; Condra C; Gould RJ; Connolly TM
    Thromb Res; 1995 Mar; 77(5):453-63. PubMed ID: 7778060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP.
    Lecompte T; Potevin F; Champeix P; Morel MC; Favier R; Hurtaud MF; Schlegel N; Samama M; Kaplan C
    Thromb Res; 1990 Jun; 58(6):561-70. PubMed ID: 2117306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ouabain affects platelet reactivity as measured in vitro.
    Prodouz KN; Poindexter BJ; Fratantoni JC
    Thromb Res; 1987 Apr; 46(2):337-46. PubMed ID: 3111004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actinoidin: a new inhibitor of ristocetin- and ristomycin-induced platelet agglutination.
    Boda Z; Solum NO; Sztaricskai F; Rak K
    Thromb Res; 1980 Mar; 17(5):603-10. PubMed ID: 6247776
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methionine-enkephalin does not alter human platelet aggregatory response.
    Given MB; Sander GE; Giles TD
    Thromb Res; 1985 Dec; 40(5):711-4. PubMed ID: 3937285
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of recombinant hirudin on cytosolic Ca2+ concentrations using different platelet stimulators.
    Kirchmaier CM; Bellinger OK; Schulz B; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():121-6. PubMed ID: 1894187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human platelet aggregation by phospholipase-A.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Thromb Res; 1976 Oct; 9(4):335-44. PubMed ID: 982355
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.